Skip to main content
Advances in Nutrition logoLink to Advances in Nutrition
. 2021 Jun 17;12(6):2372–2386. doi: 10.1093/advances/nmab068

Female Fertility and the Nutritional Approach: The Most Essential Aspects

Kinga Skoracka 1,, Alicja Ewa Ratajczak 2, Anna Maria Rychter 3, Agnieszka Dobrowolska 4, Iwona Krela-Kaźmierczak 5
PMCID: PMC8634384  PMID: 34139003

ABSTRACT

Infertility is an increasing problem that affects couples attempting pregnancy. A growing body of evidence points to a link between diet and female fertility. In fact, data show that a diet high in trans fats, refined carbohydrates, and added sugars can negatively affect fertility. Conversely, a diet based on the Mediterranean dietary patterns, i.e., rich in dietary fiber, omega-3 (ɷ-3) fatty acids, plant-based protein, and vitamins and minerals, has a positive impact on female fertility. An unhealthy diet can disrupt microbiota composition, and it is worth investigating whether the composition of the gut microbiota correlates with the frequency of infertility. There is a lack of evidence to exclude gluten from the diet of every woman trying to become pregnant in the absence of celiac disease. Furthermore, there are no data concerning adverse effects of alcohol on female fertility, and caffeine consumption in the recommended amounts also does not seem to affect fertility. On the other hand, phytoestrogens presumably have a positive influence on female fertility. Nevertheless, there are many unanswered questions with regard to supplementation in order to enhance fertility. It has been established that women of childbearing age should supplement folic acid. Moreover, most people experience vitamin D and iodine deficiency; thus, it is vital to control their blood concentrations and consider supplementation if necessary. Therefore, since diet and lifestyle seem to be significant factors influencing fertility, it is valid to expand knowledge in this area.

Keywords: diet, female fertility, nutrition, preconception, supplementation


Statement of Significance: This manuscript provides the current knowledge and a holistic view of diet and supplementation with regard to female fertility.

Introduction

Infertility—a failure to achieve pregnancy after 12 mo of unprotected and routine sexual intercourse—affects many reproductive-aged couples attempting pregnancy (1, 2). It is estimated that ∼15% of couples worldwide experience difficulty becoming pregnant; however, female infertility contributes to only 35% of overall infertility cases, 20% of cases are related to both women and men, 30% involve problems only on the part of men, whereas 15% of infertility cases remain unexplained (3, 4). According to the WHO, infertility may affect ∼80 million women worldwide (5). Female infertility is defined as infertility caused primarily by female factors, such as ovulation derangements, reduced ovarian reserve, reproductive system disorders, or chronic diseases. Primary female infertility is diagnosed in women who have never borne a child. Secondary female infertility affects women who have given birth to a live child or who experienced a miscarriage but who simultaneously are unable to establish clinical pregnancy (6). Key definitions are provided in Table 1. Besides physiological, age-related factors, female fertility is also affected by the conditions related to the pathophysiology of the reproductive organs and several other factors, such as the environment and lifestyle. Endometriosis, deregulated ovarian functions, tubal infections, and cervical and uterine factors constitute the most common reproductive pathologies; however, the etiology of some female infertility cases remains unknown (7, 8).

TABLE 1.

Definitions of essential terms according to the International Glossary on Infertility and Fertility Care, 2017 (6)

Term Definition
Fertility The capacity to establish a clinical pregnancy.
Infertility A disease characterized by the failure to establish a clinical pregnancy following 12 mo of regular, unprotected sexual intercourse, or due to an impairment of a person's capacity to reproduce, either as an individual or with his/her partner.
Female infertility Infertility caused primarily by the female factors encompassing the following: ovulatory disturbances; diminished ovarian reserve; anatomical, endocrine, genetic, functional, or immunological abnormalities of the reproductive system; chronic illness; and sexual conditions incompatible with coitus.
Male infertility Infertility caused primarily by male factors encompassing the following: abnormal semen parameters or function; anatomical, endocrine, genetic, functional, or immunological abnormalities of the reproductive system; chronic illness; and sexual conditions incompatible with the ability to deposit semen in the vagina.

There is growing interest in lifestyle (including diet and physical activity), psychological stress, socioeconomic factors, BMI, smoking, alcohol, caffeine, and psychoactive substances in the context of fertility (9). Lifestyle—including caloric intake and diet composition in terms of vitamins, protein, lipids, carbohydrates, as well as the mineral content—seems to be especially vital in the context of infertility caused by endometriosis and ovulation disorders (9–12). Interestingly, the frequency and intensity of physical activity may differently affect fertility—intensive sports, influencing the hypothalamus-pituitary axis, may lead to hypothalamic amenorrhea and subsequently lead to infertility. However, moderate physical activity is recommended to improve ovarian function and fertility, especially among women with obesity or unable to handle stressful situations (11, 13). Moreover, many studies are currently investigating the association between the intestinal microbiota and female fertility.

In view of the abovementioned factors, it is vital to adopt a holistic approach to infertility treatment in both women and men, including many specialists (e.g., physicians, dietitians, physiologists, physiotherapists). In our nonsystematic review, we aimed to summarize the current knowledge regarding dietary aspects in female infertility. However, due to a lack of clear outcomes and the small number of intervention studies, we could not formulate dietary recommendations for reproductive-aged women planning a pregnancy. Our paper does not address the topic of diet and male infertility, although we emphasize that it is crucial to focus on the lifestyle and dietary factors in male infertility treatment, especially with regard to sperm quality. We devoted a separate paper to this area including a wide range of both topics (14).

Current Status of Knowledge

We performed a literature search of MEDLINE (PubMed) searching for terms such as the following: fertility, fertility diet, female fertility, PCOS, endometriosis, infertility, infertility treatment. Since our paper is a narrative, not a systematic review, we may not have included all studies, and we must acknowledge a certain publication bias. However, every author of this publication conducted the literature search independently.

Dietary habits and female fertility

Many researchers still investigate the influence of diet on fertility. Although there is undoubtedly an association between dietary habits and fertility, many questions remain unanswered. An individual diet, which comprises other comorbidities and lifestyle, is especially essential (15). In this section, we compared 2 different nutritional approaches which differently affect both female and male fertility.

The Mediterranean diet

As current studies indicate, a diet based on the Mediterranean diet (MeD) recommendations positively affects mental and physical health. The MeD has also been associated with favorable changes in insulin resistance, metabolic disturbances, and the risk of obesity, which is crucial in the context of fertility (5, 15). The MeD is characterized by a high consumption of vegetables (including pulses), fruits, olive oil, unrefined carbohydrates, low-fat dairy and poultry, oily fish, and red wine, with a low consumption of red meat and simple sugars (16).

In a review summarizing the main findings of a prospective cohort including 22,786 participants with a mean age of 35 y, a positive association between adherence to the MeD and fertility was suggested (16). Moreover, studies show that healthy dietary patterns can also increase the chances of live birth among women using assisted reproductive technology (ART) (17, 18). In a large cohort study by Chavarro et al. (19) in 17,544 women planning a pregnancy or who became pregnant during the study, there was an association between adherence to the pro-fertility diet (similar to the MeD) and a lower risk of infertility caused by ovulation disorders. The pro-fertility diet was characterized by a lower consumption of trans-fatty acids (TFAs) and a higher consumption of MUFAs and plant-derived protein, and decreased consumption of animal protein, low glycemic index foods, high-fiber foods, and—interestingly—high-fat dairy. Women following the pro-fertility diet consumed more nonheme iron and more frequently, i.e., at least 3 times/wk, took multivitamins, in particular group B vitamins (e.g., folic acid), consumed more coffee and alcohol, and were more physically active.

Kermack et al. (20) reported that supplementation of omega-3, vitamin D, and olive oil, which imitated the MeD, before in vitro fertilization did not affect the rate of embryo cleavage. The MeD correlated with RBC folate and serum vitamin B-6. Additionally, higher adherence to the MeD by couples undergoing in vitro fertilization increased the probability of pregnancy (21). It should be noted that a part of the MeD is moderate wine drinking and, for women, this equals 1 glass of red wine daily, although it may be quite controversial in the context of female fertility. We explain what impact alcohol consumption has on fertility later in this article. However, while the majority of research studies indicate dose-dependent relations between fertility and alcohol consumption, it should be taken into account that a number of pregnancies remain unplanned. Nonetheless, there are evidence-based recommendations to exclude alcohol from the diet of pregnant women (22).

The Western-style diet

In contrast to the MeD, the Western-style diet (WsD) is rich in refined and simple carbohydrates (mostly sugar, sweets, and sweetened beverages) and red and processed meat. Moreover, it is characterized by a low intake of fresh fruits and vegetables, unrefined grains, low-fat poultry, and fish. It could also be described according to its high caloric, fat, and high glycemic index intake, with a low consumption of dietary fiber and vitamins (23, 24).

According to the conducted studies, the WsD decreased IL-1RA concentrations and the cortisol-cortisone ratio in the follicular fluid, and reduced the number of blastocysts (25). Moreover, a higher consumption of fast food and a lower intake of fruit were associated with infertility, and with a moderate increase in the time to become pregnant (26). Additionally, an animal study indicated that the WsD altered ovarian cycles and affected hormone concentrations, decreasing progesterone and anti-Müllerian hormone. The study also demonstrated that the WsD increased the number of antral follicles and delayed the time to the estradiol surge (27).

It has been shown that a diet with a high glycemic index and rich in animal protein, TFAs, and SFAs may negatively affect fertility (5). These aspects will be discussed later in the paper. However, it should be noted that studies investigating the direct relation between the WsD and fertility are still necessary. A comparison between the MeD and the WsD with regard to female fertility is presented in Table 2.

TABLE 2.

Characteristics of the Mediterranean and the Western-style diets, and their influence on female fertility1

Diet characteristics
Source of fat or fat type Meat and fish Dairy Grains and legumes Fruits and vegetables Other Influence on fertility References
Mediterranean diet MUFAs and PUFAs from nuts and olive oil Poultry, moderate fish consumption High consumption Whole grain cereals, high consumption of legumes Mostly fresh vegetables and fruits, high intake of dietary fiber Moderate consumption of red, dry wine, low consumption of sweets Direct: Increases chances of fertilization, supports ART (17–19, 28–32)
Western-style diet  SFAs and TFAs from processed foods, meat, and fast-food Red meat, processed meat Low consumption Refined cereals, low consumption of legumes Low intake of fresh fruits, vegetables, and dietary fiber High consumption of sweets and sweetened beverages Indirect: Increases the risk of IR, T2D, and PCOS; impairs ovulation (5, 23, 24)

1ART, assisted reproductive technology; IR, insulin resistance; PCOS, polycystic ovary syndrome; T2D, type 2 diabetes; TFA, trans-fatty acid.

Dietary compounds and female fertility

Carbohydrates

Both insulin sensitivity and glucose metabolism can significantly affect ovulation and female fertility. In terms of carbohydrates, glycemic index and load are especially essential. Possibly, the consumption of high glycemic index products can increase insulin resistance, dyslipidemia, and oxidative stress, which negatively affects fertility and the ovarian functions (15, 33).

Insulin regulates metabolism but also reproductive functions; it can modulate ovarian steroidogenesis as well as hyperinsulinemia which are correlated positively with hyperandrogenism and ovulation disorders. Insulin is also the primary regulator of the production of sex hormone–binding globulin (SHGB) among women with polycystic ovary syndrome (PCOS). High glycemic index and load have been associated with higher fasting glucose concentrations, hyperinsulinemia, and insulin resistance, and therefore with higher concentrations of insulin-like growth factor I (IGF-I) and androgens, which can lead to endocrine disturbances and, thus, may alter the maturation of oocytes (5). A large cohort study conducted in 18,555 women without a history of infertility, who planned or became pregnant during the study, showed that a higher consumption of carbohydrates at the cost of naturally occurring fats and with a high glycemic index was positively associated with infertility due to ovulation disorders (34). These results were confirmed by other studies where the higher consumption of high glycemic index products and carbohydrates, when compared with fiber intake, and a high consumption of simple sugars were related to lower chances of becoming pregnant (33). The main sources of added sugars are carbonated beverages, which can negatively affect fertility (35). Moreover, Machtinger et al. (36) observed that the consumption of sweetened, carbonated beverages—independently of the caffeine intake—can decrease the chances of reproductive success by means of ART. It has also been shown that the consumption of carbonated beverages is associated with increased concentrations of free estradiol (37).

Undoubtedly, both the amount and the type of carbohydrates are essential in the context of a pro-fertility diet among women with lipid and glucose metabolism disturbances. However, this aspect is also essential in the diet of reproductive-aged women planning to become pregnant.

Fat

Fats constitute a vital dietary compound affecting fertility. Hohos and Skaznik-Wikiel (38) suggested that a high-fat diet can be associated with changes in the reproductive functions, including menstrual cycle length, reproductive hormone concentrations [e.g., luteinizing hormone (LH)], and embryo quality in the ART cycles.

Furthermore, it seems that the quality of fat is more important than its amount. The Chavarro et al. study (39) comprising 18,555 women planning a pregnancy or who became pregnant during the study demonstrated that increasing the intake of TFAs by even 2% resulted in a significant increase in infertility risk due to ovulation disorders. In contrast, Mumford et al. (40) did not observe associations between TFAs, SFAs, and the relative risk of anovulation in the BioCycle Study. It is worth bearing in mind that the Chavarro et al. study was conducted in the United States between 1991 and 1995, and the first cohort study indicating the harmfulness of TFAs appeared only in 1993 (41). On the other hand, the BioCycle Study was conducted between 2005 and 2007, when the United States already had mandatory labeling of the TFA content in foods containing ≥0.5 g TFAs/serving (42). Furthermore, in another study, the negative influence of TFA intake on fertility was observed among 1290 American women planning a pregnancy. However, this association was not observed among the Danish women and, as the authors suggested, may be associated with a low consumption of TFAs among this cohort due to the 2003 Danish law requiring a limit of TFAs in fats and oils to 2% of the total fatty acids (FAs) (42, 43).

TFAs have proinflammatory properties and may increase insulin resistance, increasing the risk of developing type 2 diabetes or other metabolic disturbances, including PCOS, which can negatively affect fertility (39, 44–47). It has been assumed that the direct negative effect of TFAs is associated with their influence on and a decreased expression of peroxisome proliferator–activated receptor γ (PPAR-γ). Moreover, the intake of TFAs was associated with the incidence of endometriosis (48). According to the Global Burden of Diseases Study, differences in TFA consumption between countries in 2010 range from 0.2% to 6.5% of energy intake, whereas the mean global TFA intake is 1.4% of the total energy intake (39). The highest intake of TFAs is observed in Egypt, Pakistan, Canada, Mexico, and Bahrain, although the WHO recommends limiting consumption of TFAs to <1% of total energy intake (40). Some countries, following the example of Denmark, have taken action to limit the amount of TFAs in food by introducing TFA limits in food or by compulsory labeling of products containing TFAs. It seems that prohibiting TFAs is the most effective approach to reduce the amount of TFAs in the food supply (49). In countries where there are no limits on the amount of TFAs in food, products high in TFAs can still be found in supermarkets and are often cheaper than their TFA-free counterparts. Therefore, it seems that it is necessary to continuously increase the nutritional awareness of the public, as well as to learn how to read labels in order to make proper nutritional choices (44).

On the other hand, ɷ-3 FAs can positively affect fertility, as they play an essential role in steroidogenesis and have significant anti-inflammatory properties (50, 51). Currently, the available studies indicate that ɷ-3 FAs from oily fish or supplements have a beneficial effect on the growth and maturation of oocytes, decrease the risk of anovulation, and improve embryo morphology, and are associated with higher concentrations of progesterone (40, 51, 52). However, the results of the association between ɷ-3 FAs and fertility are contradictory. In numerous studies, no association, or insufficient evidence, has been observed (39, 43, 53–56). It seems, however, that ɷ-3 FAs—by increasing insulin sensitivity and improving the lipid profile—may be helpful in the treatment of PCOS, although more studies are required (57). The supplementation of ɷ-3 FAs decreases follicle-stimulating hormone (FSH) among women with normal weight, which has not been observed in women with obesity. On the basis of this study, it is possible to suggest that ɷ-3 FAs extend the reproductive lifespan (58). Nevertheless, further investigations among women with a diminished ovarian reserve are critical. Nassan et al. (59) demonstrated that the consumption of fish, which is a good source of ɷ-3 FA, was associated with a higher probability of live birth following ART. On the other hand, according to the study by Stanhiser et al. (60), no association was observed between concentration of ɷ-3 FAs and the probability of becoming pregnant naturally. Additionally, the consumption of seafood increases sexual intercourse frequency and provides greater fecundity (61).

Conversely, MUFAs can bind with the PPAR-γ receptor, thus decreasing inflammation and positively affecting fertility. In fact, studies have presented a positive correlation between the consumption (62) and concentration in plasma (53) of MUFAs, fertility, and the time to achieve pregnancy.

Studies investigating the influence of dairy-derived fats on fertility are interesting, although the results are often contradictory. On the one hand, according to the study by Chavarro et al. (63), the consumption of low-fat dairy—including low-fat milk, yogurt, and cottage cheese—increased the risk of infertility due to anovulation, whereas high-fat dairy increased fertility. This may possibly be associated with a higher content of estrogen and fat-soluble vitamins in high-fat dairy. Moreover, it could also be assumed that the beneficial effect of dairy-derived fat may be associated with the presence of the trans-palmitoleic acid, which seems to improve insulin sensitivity (64, 65). On the other hand, Wise et al. (66) did not confirm that the consumption of high-fat dairy is correlated with increased fecundity, and they did confirm that consuming lactose and low-fat dairy did not negatively affect fertility.

It is vital to note that the consumption of >3 portions of dairy/d decreases the risk of endometriosis diagnosis by 18%, when compared with the consumption of 2 servings (67). Additionally, women consuming >4 portions of dairy daily during adolescence presented a 32% lower risk of endometriosis during adulthood than women consuming ≤1 portion (68). Moreover, the total dairy intake was positively associated with live birth among women aged ≥35 y (69).

Taking the abovementioned facts into consideration, a high consumption of MUFAs and PUFAs (including a high consumption of ɷ-3 from oily fish or from supplementation) with a low consumption of TFAs and SFAs should be recommended to childbearing-age women trying to become pregnant. Moreover, the evidence for a positive influence of reduced-fat dairy and an increased consumption of high-fat dairy is scarce; thus, it should not be recommended. However, more studies are necessary.

Protein

The next element of a fertility diet is protein. Chavarro et al. (70) suggested that animal protein consumption has been associated with a higher risk of infertility due to a lack of ovulation. In turn, the intake of plant protein increases fertility among women >32 y. The difference may stem from the disparate impact of plant and animal protein on insulin and IGF-I secretion. Insulin response is lower after plant protein consumption than following animal protein.

According to Mumford et al. (71), protein intake—in particular animal protein—correlated negatively with testosterone concentrations among healthy women. It seems that androgens, i.e., testosterone, play an important role in regulation of the ovarian function and female fertility. However, excessive androgen signaling seems to be a major factor in androgen-related reproductive disorders, since it disturbs the pathways regulating ovarian follicular dynamics (72). However, protein intake was not associated with estradiol, progesterone, LH, and FSH concentrations. Additionally, the study showed a lack of association between the total, plant, and animal (without protein from dairy products) protein intake and the amount of antral follicles among women experiencing infertility (71). On the other hand, a high protein intake from dairy products was connected with a decreased number of antral follicles, which is a biomarker predicting ovarian primordial follicle numbers (73).

Furthermore, increasing protein intake may improve carbohydrate-insulin balance, which seems to be important in treating infertility due to a lack of ovulation. It is vital to notice that protein presents the highest satiety properties, affects diet-induced thermogenesis, and protects muscle mass (74).

Future studies on protein's role in the diet of women attempting pregnancy are necessary. In fact, protein should be included in the diet in the amount recommended for the rest of the population, based on such elements as the level of physical activity. Additionally, the diet ought to contain especially plant protein sources.

Micronutrients

Folic acid and vitamins B-12 and B-6

It is possible that folic acid, vitamin B-12, and vitamin B-6 affect fertility. Studies indicate that the supplementation of folic acid (particularly in a dose higher than the recommended one for the prevention of congenital defects and combined with vitamin B-12) in the period prior to pregnancy may increase the chances of becoming pregnant and ART success. However, there is no randomized controlled trial on the impact of a high dose of folic acid associated with a positive response in observational studies (75).

In fact, fortification of cereals with folic acid increased the number of twin births in the United States. However, this possibly results from an increasing number of women using the ovulation-inducing drugs and not the increased folic acid intake (76). It is vital to note that folic acid supplementation has been negatively associated with a shorter length of the menstrual cycle (77). Murto et al. (78) showed that women with unexplained infertility supplemented more folic acid than fertile women. Additionally, women experiencing infertility had higher concentrations of folic acid and lower concentrations of homocysteine when compared with the control group. On the other hand, the intake of synthetic folic acid was associated with an increase in progesterone and a decreased risk of sporadic anovulation (79).

Additionally, women with methylenetetrahydrofolate reductase (MTHFR) mutation achieved a lower percentage of in vitro fertilizations than subjects without a mutation. On the other hand, the prevalence of implantation and clinical pregnancy was similar in both groups (80). Moreover, the concentration of vitamin B-12 and folic acid was not associated with in vitro fertilization probability (81).

The impact of folic acid, vitamin B-12, and vitamin B-6 on fertility is possibly associated with homocysteine metabolism. A lack of vitamin B-12 disturbs the remethylation process, whereas vitamin B-6 deficiency directly leads to an accumulation of homocysteine due to the induction of an enzyme called cystathione b-synthase. Consequently, the transsulfuration process, through which histamine is converted to cysteine, decelerates (82). Clinical studies show that hyperhomocysteinemia combined with a low concentration of folic acid constitutes a risk factor for recurrent miscarriage. Additionally, a higher homocysteine concentration has been associated with a faulty vascularity of chorion among women with a recurrent early pregnancy loss (83). In fact, it is homocysteine that induces trophoblast apoptosis and decreases chorionic gonadotropin (84), whereas a high concentration of homocysteine causes endothelial inflammation through increased expression of proinflammatory cytokines (85). Moreover, an increased homocysteine concentration in the ovarian follicle liquid may affect the interaction between the ovarian follicle and the spermatozoon, decreasing the chances of fertilization (86). Additionally, hyperhomocysteinemia increases oxidative stress, which affects women's fertility (87).

A cohort study including 259 women who were regularly menstruating and not using hormonal contraceptives and diet supplements showed a connection between a higher homocysteine concentration and an increased risk of a lack of ovulation by 33%. Furthermore, a higher folic acid to homocysteine ratio decreased the risk of anovulation by 10% (88). In fact, mild homocysteinemia is often observed in mothers of children with neural tube defects (89). It is vital to note that women experiencing PCOS present homocysteine metabolism disorders and a higher concentration of homocysteine in comparison to healthy women (90). The supplementation of folic acid is recommended for women with PCOS (91).

Future studies are necessary to confirm whether lowering homocysteine concentrations through diet or supplementation with folic acid and vitamins B-6 and B-12 may improve ovarian function in women attempting pregnancy.

According to the recommendations, women should supplement with folic acid in the period prior to pregnancy, since supplementation is safe and does not cause side effects. Nevertheless, there is a further need for randomized trials confirming the impact of folic acid supplementation on fertility, as well as in doses higher than recommended for preventing neural tube defects (88).

Vitamin D

Vitamin D likely participates in the modulation of female reproductive functions. Studies have demonstrated that vitamin D receptors are expressed in numerous tissues of the reproductive organs, such as ovaries, endometrium, placenta, pituitary gland, and hypothalamus (92–95). Additionally, vitamin D affects various endocrine processes and the steroidogenesis of sex hormones (96, 97). A study indicated that serum concentration of vitamin D may be associated with PCOS and endometriosis and affects the success of ART (98). On the other hand, there was no association between vitamin D and fertility among healthy subjects (99). The deficiency of vitamin D affects calcium balance, increases the production and secretion of proinflammatory cytokines, as well as participates in glucose metabolism through stimulating the synthesis and secretion of insulin. Therefore, many studies discuss the impact of vitamin D on inflammatory diseases, including diabetes and cardiovascular disease (100). Moreover, vitamin D may be an essential component of PCOS development by means of regulating glucose metabolism (92). In fact, insulin resistance and hyperinsulinemia are associated with enhanced androgen synthesis in the ovaries and a lower concentration of SHGB (101).

The meta-analysis by He et al. (102) showed a lack of significant differences in vitamin D concentration between women with PCOS and healthy individuals. Nevertheless, the authors emphasized a significantly varied prevalence of vitamin D deficiency among women with PCOS that was associated with comorbidities. In fact, women with PCOS with vitamin D deficiency more frequently presented endocrine and metabolic disorders than women with the normal vitamin D concentrations. It is vital to note that vitamin D has anti-inflammatory and immunomodulating properties, and its deficiency may be associated with endometriosis, which is one of the causes of infertility (103, 104). In vitro animal studies (105–108) showed that vitamin D has beneficial effects on endometrial tissues, although clinical studies on the role of vitamin D in the diagnosis and treatment of endometriosis provide inconclusive evidence (109–111).

Furthermore, in a meta-analysis, Chu et al. (112) suggest that there is an association between vitamin D status and ART results. Additionally, the authors highlighted that vitamin D deficiency may be an essential factor in infertility treatment using ART. On the other hand, Abadia et al. (113) reported that vitamin D may be linked to a higher rate of fertilization in women undergoing ART. Nevertheless, this was not associated with a higher probability of live birth, or pregnancy.

Future studies are necessary to assess the association between vitamin D and PCOS, endometriosis, and with women's fertility. It is vital to note that a deficiency of vitamin D is common. Individuals presenting too-low concentrations of this vitamin should supplement vitamin D in doses of ≥1500–2000 IU/d (114).

Minerals

The proper concentration of minerals is essential for many physiological processes, including maintaining the normal quality of oocytes and embryo fertilization, maturation, and implantation (115). A deficiency of minerals may disturb fertility; therefore, women should pay attention to the proper intake of minerals and supplement the elements that could be deficient. One study showed that many women fail to meet nutrient needs—particularly in terms of folic acid, calcium, iodine, iron, selenium, vitamin D, and vitamin B-12—and thus have lower blood concentrations (116). Calcium, iron, zinc, magnesium, iodine, and selenium are especially essential with regard to fertility.

Calcium affects blood vessels, muscle contractions, nerve conduction, and hormone secretion. Additionally, the fetus uses the mother's skeletal calcium for bone growth. Therefore, the recommended dose of calcium constitutes a crucial element in the diet of women of childbearing age (117). Additionally, calcium deficiency may decrease vitamin D concentrations and increase the risk of hypertension, and pre-eclampsia. However, no studies refer to the validity of the supplementation of or fortification with calcium in the period before pregnancy to prevent pregnancy complications (118, 119).

Few studies have reported on the association between serum iron concentration and fertility. However, both excess and deficiency of iron may negatively affect fertility (120). According to Hahn et al. (121), total or heme iron intake was poorly associated with fecundity, particularly among women with a potential risk of iron deficiency, e.g., women with frequent and heavy periods. On the other hand, a prospective study showed that the supplementation of total and nonheme iron may decrease the risk of infertility due to disorders of ovulation (122).

Another key element is iodine, affecting thyroid gland function, which is essential for proper fertility. In a study conducted in 501 women experiencing moderate or severe iodine deficiency, pregnancy was delayed, and the chances of becoming pregnant in each cycle decreased by 46% when compared with women who were not iodine deficient. Among women with mild iodine deficiency, this association was minimal (123, 124). It is vital to note that mild and moderate iodine deficiency is common among women of reproductive age around the world (125–127).

Grieger et al. (128) reported that low serum concentrations of zinc and selenium were associated with a 1-mo longer period before achieving pregnancy. Additionally, a deficiency of selenium and copper, but not zinc, was linked to a higher risk of infertility. On the basis of limited studies, the impact of zinc and copper concentration on women's fertility remains unclear, and future research is required (128).

Selenium also affects thyroid gland function. Additionally, it is an antioxidant participating in the reduction of oxidative stress. In fact, selenium possibly influences the growth and maturation of oocytes. Therefore, an adequate supply of selenium is necessary (129).

Magnesium takes part in glucose metabolism; hence, it may be vital for women with PCOS and metabolic disorders. The proper serum concentration of magnesium is probably associated with increased insulin sensitivity of tissues (130, 131).

A balanced and varied diet allows for covering the requirements of daily nutrients. However, supplementation is necessary in the case of mineral deficiency, especially with regard to iodine (132, 133).

Phytoestrogens

The impact of phytoestrogens on fertility has been a highly controversial topic for years. Phytoestrogens are compounds of plant origin, including isoflavones found in soy products; lignans found in nuts, seeds, and cruciferous vegetables; as well as coumestans found in sprouts, peas, and beans (104).

On one hand, numerous scientific studies indicate the preventive effect of phytoestrogen consumption on the development of breast and endometrial cancer, fibroids, osteoporosis, cardiovascular diseases, inflammation, metabolic syndrome, and obesity (104–109). In fact, soy isoflavone supplementation was associated with an increase in the number of live births following clomiphene therapy, increased endometrial thickness, pregnancy rates following insemination, and in vitro fertilization. Furthermore, soy consumption was associated with an increased chance of live birth using ART (134–137).

On the other hand, certain studies point to endocrine system disorders as negative effects of phytoestrogen consumption. In the Adventist Health Study, women who consumed a greater amount of isoflavones were at an increased risk of never becoming pregnant and being childless (138). In contrast, a cohort study by Mumford et al. (139) found no association between soy intake and fertility.

In an analysis of 2 cohorts comprising women planning a pregnancy in North America and Denmark, which included 4880 and 2898 women, respectively, no strong association was observed between dietary phytoestrogen intake and the chances of becoming pregnant (140). At the same time, it is worth considering that, in Western countries, the average intake of phytoestrogen is <2 mg, and in European countries, the intake is even lower than 1 mg compared with the ∼50 mg consumed in Asian countries (141).

Undoubtedly, phytoestrogens are still not fully understood; therefore, further research in this area is desirable (142).

Gluten

Among women struggling with infertility, a discussion of the negative influence of gluten on fertility is relatively common—for instance, the study by Harper and Bold (143) asked subjects about their motivations for eliminating gluten from their diet. However, according to the recommendations, the exclusion of gluten from the diet is not recommended for the general population, and there is no evidence that it is beneficial in non-celiac individuals (144).

Castaño et al. (145) conducted a meta-analysis that included a total of 23 research studies, and aimed to assess the prevalence of celiac disease seroprevalence in women with fertility disorders. The study group consisted of women with overall infertility, women with idiopathic infertility, and women with recurrent spontaneous abortions. The studies included in the meta-analysis did not comprise women with a diagnosed celiac disease or allergy to wheat proteins. The meta-analysis demonstrated that celiac disease seroprevalence among women with infertility amounted to ∼1.3–1.6%, which allows estimating that women experiencing such disorders are 3 times more likely to develop celiac disease. However, due to the small number of respondents, it is impossible to precisely calculate the total incidence of the association between celiac disease and fertility disorders.

There are no recommendations indicating the benefits of eliminating gluten from the diet of all women experiencing infertility. It should be noted that many research studies indicate a much lower nutritional value of gluten-free diets compared with traditional diets (146). Nevertheless, such frequent diagnoses of previously undiagnosed celiac disease among women experiencing infertility raises the question of whether it is not reasonable to conduct celiac disease screening tests in women with infertility (147). However, there can be no doubt that women diagnosed with celiac disease attempting pregnancy should follow a gluten-free diet (148).

Antioxidants

The current knowledge indicates that oxidative stress, i.e., the imbalance between reactive oxygen species (ROS) and antioxidants leading to cell damage, plays an essential role in the development of infertility (149–151).

It is assumed that cytochrome P450 is involved in the production of ROS, and oxidative stress subsequently promotes the development of endometriosis, hydrosalpinx, and PCOS. Importantly, oxidative stress has also been shown to be associated with idiopathic infertility, recurrent miscarriage, and pre-eclampsia (152–155).

It has been proven that ROS entering the ovum causes damage, which has an important impact on the fertilization process and its further success, as well as the entire process of embryogenesis, which constitutes the reason for a wider use of antioxidants in the treatment of infertility (152, 155). The possible mechanisms of their action include improving blood circulation in the endometrium, lowering sex hormone concentrations, increasing tissue insulin sensitivity, and affecting ovulation, prostaglandin synthesis, and steroidogenesis (155, 156).

The most common environmental causes that exacerbate oxidative stress comprise environmental pollutants, smoking, drug use, alcohol abuse, malnutrition, poor diet, and chronic diseases, including obesity and autoimmune diseases (156).

A Cochrane review (157) indicates that there is evidence based on very-low-quality research suggesting that women experiencing infertility may benefit from antioxidant supplementation. The researchers emphasize that the quality of the available studies is not good enough to establish the possible side effects of the antioxidant supplementation. However, it is worth briefly discussing the individual antioxidants and their potential impact on fertility.

It is worth noting that women with endometriosis have been shown to have a lower supply of vitamins A, C, and E, as well as copper and zinc, than healthy women without fertility disorders (158–160). In fact, a 4-mo-long supplementation of vitamins C and E resulted in a reduction in oxidative stress (158). Additionally, higher levels of oxidative stress markers and lower serum concentrations of vitamins C and E have been observed in women suffering from PCOS (161, 162).

Vitamin C, vitamin E, and vitamin A are among some of the most potent antioxidants. Vitamin C, which is present in high concentrations in the cytosol of the oocyte, is essential, as it participates in collagen synthesis, which is significant for the growth of the Graaf follicle, ovulation, and the luteal phase. Moreover, vitamin C also helps restore oxidized vitamin E and glutathione (155). The benefits of vitamin E supplementation include improved epithelial growth in the blood vessels and the endometrium.

Moreover, inositol supplementation may be essential, particularly in PCOS, due to its insulin sensitivity–enhancing and insulin response–modulating effects (163, 164). Furthermore, inositol derivatives are important secondary messengers of the gonadotropins LH and FSH. Inositol has been shown to regulate the menstrual cycle, improve ovulation, and favorably influence metabolic parameters in women with PCOS, although there is a lack of research evaluating its association with the chances of pregnancy, miscarriage, or the number of deliveries (165).

Additionally, l-carnitine appears to be an important antioxidant. Research studies indicate that its supplementation relieves disorders of the reproductive system, such as PCOS, endometriosis, or amenorrhea (166–168). The alleviating effect of l-carnitine on endometriosis may be due to its impact on the hormonal balance, decreased cytokine release, and apoptosis. By means of its effect on the hypothalamic-pituitary-gonadal axis, l-carnitine regulates the concentrations of gonadotropins and sex hormones and thus may be beneficial for the course of PCOS and the menstrual cycle (166). l-Carnitine also increases energy production by oocytes through B-oxidation, and is involved in combating oxidative stress (166, 169). Interestingly, the bioavailability of carnitine from food is much higher than from supplements (170). Sharkwy et al. (171) conducted research to compare the clinical and metabolic profiles between N-acetylcysteine (NAC) and l-carnitine among women with clomiphene citrate–resistant PCOS. The study demonstrated that both NAC and l-carnitine were effective in improving pregnancy and ovulation rates among women with clomiphene citrate–resistant PCOS. However, although NAC was superior in increasing insulin sensitivity, only l-carnitine improved the lipid profile. In contrast, a study by Behrouzi Lak et al. (172) indicates that, in patients with PCOS without clomiphene citrate resistance, NAC is ineffective in inducing or augmenting ovulation in the PCOS patients who are able to undergo intrauterine insemination and, according to the authors, it cannot be recommended as an adjuvant to clomiphene citrate in such patients.

Gut microbiota

The composition of the diet also plays an essential role in shaping the intestinal microbiota. Dietary components can either directly impact the gut microbiota by promoting or inhibiting its growth, or indirectly by means of influencing metabolism and the immune system, which can also lead to changes in the gut microbiota composition (173).

Studies indicate that the consumption of a Western diet has been associated with an increase in Bacteroides phyla and Ruminococcus. On the other hand, a high-fat diet has been positively correlated with the amount of Bacteroides and Actinobacteria simultaneously decreasing Firmicutes and Proteobacteria, which are positively correlated with the consumption of a high-fiber diet. Moreover, diets that are based on animal products have been associated with higher levels of Alistipes, Bilophila, and Bacteroides and with reduced levels of Firmicutes. In contrast, diets high in complex carbohydrates contribute to a beneficial increase in Bifidobacteria, with Prevotella being the most dominant bacterial type among vegetarians. The composition of the intestinal microbiota, largely dependent on diet, plays a vital role in the proper functioning of the immune system. Additionally, intestinal dysbiosis induces local inflammation and an increase in intestinal permeability, which is associated with a decrease in Bifidobacteria. These bacteria, in turn, can reduce LPS and improve the state of the intestinal barrier. All of the above-mentioned facts mean that the Western diet may, in fact, increase the risk of systemic inflammation (174, 175).

Coffee and alcohol

A significant majority of research studies indicate that high caffeine consumption may constitute a potential factor associated with an increased time to achieving pregnancy and an increased risk of pregnancy loss (5, 7, 11, 176). In addition, a dose-dependent association has been observed between caffeine consumption during pregnancy and stillbirth, childhood acute leukemia, delayed fetal growth, and the negative effects on a child's birth weight, as well as on overweight and obesity in children (177, 178). According to the European Food Safety Authority, for pregnant women and for women attempting pregnancy, up to 200 mg of caffeine/d is recommended. Similarly, the American College of Obstetricians and Gynecologists indicates that the intake of up to 200 mg of caffeine does not appear to be a main factor leading to miscarriage or preterm delivery (179, 180). Nevertheless, in the latest review paper including 48 original observational studies and meta-analyses, James (178) emphasized that the assumptions about safe maternal caffeine consumption levels are not supported by the current evidence, and indicated a necessity for a radical revision of the current recommendations. Simultaneously, it is worth noting that the source of caffeine is not only coffee, but also tea, soft drinks, cocoa, or certain drugs (176).

On the other hand, there is evidence suggesting that alcohol consumption, especially heavy drinking and chronic alcohol consumption, has been connected to reduced fertility and a higher risk of developing menstrual disorders (22, 181). However, the mechanism in which excessive alcohol consumption negatively affects fertility has not been determined (5). A suggested hypothesis for the negative influence of alcohol intake on female fertility includes altering endogenous hormone concentrations, a direct impact on the maturation of the ovum, ovulation, early blastocyst development, and implantation (181). It is also crucial to stress that alcohol consumption during pregnancy can result in adverse effects in offspring development, such as fetal alcohol spectrum disorders (182).

Summary of the Data Regarding a Diet for Women Planning a Pregnancy

Diet and nutritional patterns are undoubtedly significant for both male and female fertility; thus, it is worth investigating the components of the diet and their influence on fertility. Further research is needed to develop standardized dietary recommendations for women planning a pregnancy. The current knowledge on the effects of individual nutrients and their sources is summarized in Table 3. Further research is necessary to develop standardized dietary recommendations, which should be given to women planning a pregnancy, and individualized in case of problems with achieving pregnancy. It is important to emphasize the valid role of a clinical dietitian, who should actively participate in the care of women planning a pregnancy and, above all, be a member of a multidisciplinary team in infertility treatment centers.

TABLE 3.

The effects of the selected dietary components on female fertility1

Nutrient Summary Recommended food sources References
Carbohydrates Added sugars and a high glycemic index have a negative effect on fertility. Vegetables and fruit, whole-grain pasta, whole-grain bread, grains, rice, cereals (5, 15, 33–35, 37)
Fat Intake of TFAs and excess SFAs appears to negatively affect female fertility. The direct effect of PUFAs on fertility is unclear, while MUFAs appear to have a positive effect on female fertility. Oily fish, rapeseed oil, flaxseed oil, olive oil and other plant oil, avocado, nuts, seeds (39, 43, 53–56, 62)
Proteins It is vital to include good sources of proteins in the diet. Plant proteins appear to have a positive impact on fertility, while animal protein—especially from processed meat—a negative impact. Legumes, fish, lean meat, eggs, dairy products (particularly fermented) (70, 71, 73)
Dairy Studies regarding dairy are inconsistent—although dairy should be consumed as a part of healthy diet, it is hard to determine if it should be high-fat or low-fat in order to increase fertility. Taking current studies into the account, high-fat dairy should not be recommended in order to increase fertility, as it can have a negative impact on other risk factors for fertility. Low-fat dairy, especially fermented dairy products (63, 66)
Iodine Iodine is essential for the proper development of the fetus and proper thyroid function. While mild and moderate iodine deficiency is common among women, it is crucial to pay special attention to the supply of iodine by women planning a pregnancy. Iodized salt, dairy, seafood (123, 125, 127)
Folic acid It appears that folic acid supplementation, particularly combined with vitamin B-12, may increase the chance of pregnancy and ART success. There is a need for the randomized trials. Green-leafy vegetables, eggs, poultry (75, 81, 88)
Vitamin D Serum vitamin D concentrations may be associated with PCOS and endometriosis and affect ART success. In a population of healthy, fertile individuals, there is no significant association. Fish, eggs, cheese, milk, dairy (98, 99, 112)
Antioxidants Very-low-quality evidence suggests that antioxidant supplementation may be beneficial for women suffering from infertility. More research is needed to assess the risk of the possible side effects. Inositol, l-carnitine, and NAC require particular attention due to the increasing number of studies positively assessing their impact on parameters related to female fertility. Fresh fruits (especially berry fruits) and vegetables, vegetable oil, spices (e.g., cinnamon), tea, coffee (157)
Phytoestrogens The relation of phytoestrogens to female fertility remains unclear. Studies indicate that the consumption of soy isoflavones has a beneficial effect on ART success. Pulses, flaxseed oil (134–137)
Gluten In healthy individuals, gluten does not appear to affect fertility. Not applicable No research
Caffeine High caffeine consumption may be a potential factor associated with the increased time to achieve pregnancy and an increased risk of pregnancy loss. Coffee, cocoa—in recommended amounts (5, 7, 11, 176)
Alcohol There is some evidence suggesting that excessive alcohol consumption correlates positively with reduced fertility and a higher risk of developing menstrual disorders. Not applicable (22, 181)

1ART, assisted reproductive technology; NAC, N-acetylcysteine; PCOS, polycystic ovary syndrome; TFA, trans-fatty acid.

Conclusions

Numerous questions remain unanswered, although there is no doubt that diet has an impact on female fertility. On the basis of the current knowledge, it can be confirmed that the consumption of TFAs, refined carbohydrates, and added sugars negatively affects female fertility. In contrast, a diet based on the recommendations of the MeD—rich in dietary fiber, ɷ-3 FAs, vegetable protein, vitamins, and minerals—has a positive effect on female fertility.

There are no clear guidelines on supplementation to enhance fertility in women. A properly balanced diet should provide all minerals and vitamins, except for vitamin D and folic acid, which should be supplemented. It may also be challenging to provide adequate amounts of iodine with the diet, especially in low-sodium diets and in elimination diets. Additionally, women in the period prior to pregnancy are also recommended to consume folic acid. Particularly in women considered as a risk group, serum concentrations of micronutrients and vitamins should be monitored, and in the case of deficiencies, supplementation should be introduced.

ACKNOWLEDGEMENTS

We thank TranslationLab, a biomedical translation company, for language proofreading. The authors’ responsibilities were as follows—KS and IK-K: conceptualization; KS, AER, and AMR: wrote and prepared the original draft; IK-K: reviewed and edited the manuscript, supervised the study, and had primary responsibility for the final content; AD: acquired funding; and all authors: read and approved the final manuscript.

Notes

The authors reported no funding received for this work.

Author disclosures: The authors report no conflicts of interest.

Abbreviations used: ART, assisted reproductive technology; FA, fatty acid; FSH, follicle-stimulating hormone; IGF-I, insulin-like growth factor I; LH, luteinizing hormone; MeD, Mediterranean diet; NAC, N-acetylcysteine; PCOS, polycystic ovary syndrome; PPAR-γ, peroxisome proliferator–activated receptor γ; ROS, reactive oxygen species; SHGB, sex hormone–binding globulin; TFA, trans-fatty acid; WsD, Western-style diet.

Contributor Information

Kinga Skoracka, Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, the Heliodor Swiecicki Hospital, Poznan, Poland.

Alicja Ewa Ratajczak, Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, the Heliodor Swiecicki Hospital, Poznan, Poland.

Anna Maria Rychter, Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, the Heliodor Swiecicki Hospital, Poznan, Poland.

Agnieszka Dobrowolska, Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, the Heliodor Swiecicki Hospital, Poznan, Poland.

Iwona Krela-Kaźmierczak, Department of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, the Heliodor Swiecicki Hospital, Poznan, Poland.

References

  • 1.Vander Borght M, Wyns C. Fertility and infertility: definition and epidemiology. Clin Biochem. 2018;62:2–10. [DOI] [PubMed] [Google Scholar]
  • 2.Farquhar CM, Bhattacharya S, Repping S, Mastenbroek S, Kamath MS, Marjoribanks J, Boivin J. Female subfertility. Nat Rev Dis Primers. 2019;5(1):7. [DOI] [PubMed] [Google Scholar]
  • 3.Thurston L, Abbara A, Dhillo WS. Investigation and management of subfertility. J Clin Pathol. 2019;72(9):579–87. [DOI] [PubMed] [Google Scholar]
  • 4.Leaver RB. Male infertility: an overview of causes and treatment options. Br J Nurs. 2016;25(18):S35–40. [DOI] [PubMed] [Google Scholar]
  • 5.Silvestris E, Lovero D, Palmirotta R. Nutrition and female fertility: an interdependent correlation. Front Endocrinol. 2019;10:346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zegers-Hochschild F, Adamson GD, Dyer S, Racowsky C, de Mouzon J, Sokol R, Rienzi L, Sunde A, Schmidt L, Cooke IDet al. . The international glossary on infertility and fertility care, 2017. Fertil Steril. 2017;108(3):393–406. [DOI] [PubMed] [Google Scholar]
  • 7.Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018;16(1):22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Templeton A. Infertility and the establishment of pregnancy—overview. Br Med Bull. 2000;56(3):577–87. [DOI] [PubMed] [Google Scholar]
  • 9.Aj G, Je C. Diet and fertility: a review. [Internet]. Am J Obstet Gynecol. 2018; [cited 2020 Dec 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/28844822/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Garruti G, Depalo R, De Angelis M. Weighing the impact of diet and lifestyle on female reproductive function. Curr Med Chem. 2019;26(19):3584–92. [DOI] [PubMed] [Google Scholar]
  • 11.Oostingh EC, Hall J, Koster MPH, Grace B, Jauniaux E, Steegers-Theunissen RPM. The impact of maternal lifestyle factors on periconception outcomes: a systematic review of observational studies. Reprod Biomed Online. 2019;38(1):77–94. [DOI] [PubMed] [Google Scholar]
  • 12.Nazni P. Association of western diet & lifestyle with decreased fertility. Indian J Med Res. 2014;140(Suppl):S78–81. [PMC free article] [PubMed] [Google Scholar]
  • 13.Collins GG, Rossi BV. The impact of lifestyle modifications, diet, and vitamin supplementation on natural fertility. Fertil Res Pract. 2015;1(1):11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Skoracka K, Eder P, Łykowska-Szuber L, Dobrowolska A, Krela-Kaźmierczak I. Diet and nutritional factors in male (in)fertility-underestimated factors. J Clin Med. 2020;9(5):1400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Fontana R, Della Torre S. The deep correlation between energy metabolism and reproduction: a view on the effects of nutrition for women fertility. Nutrients. 2016;8(2):87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Carlos S, De La Fuente-Arrillaga C, Bes-Rastrollo M, Razquin C, Rico-Campà A, Martínez-González MA, Ruiz-Canela M. Mediterranean diet and health outcomes in the SUN cohort. Nutrients. 2018;10(4):439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Gaskins AJ, Nassan FL, Chiu Y-H, Arvizu M, Williams PL, Keller MG, Souter I, Hauser R, Chavarro JE; EARTH Study Team . Dietary patterns and outcomes of assisted reproduction. Am J Obstet Gynecol. 2019;220(6):567.e1–e18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Karayiannis D, Kontogianni MD, Mendorou C, Mastrominas M, Yiannakouris N. Adherence to the Mediterranean diet and IVF success rate among non-obese women attempting fertility. Hum Reprod. 2018;33(3):494–502. [DOI] [PubMed] [Google Scholar]
  • 19.Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Diet and lifestyle in the prevention of ovulatory disorder infertility. Obstet Gynecol. 2007;110:1050–8. [DOI] [PubMed] [Google Scholar]
  • 20.Kermack AJ, Lowen P, Wellstead SJ, Fisk HL, Montag M, Cheong Y, Osmond C, Houghton FD, Calder PC, Macklon NS. Effect of a 6-week “Mediterranean” dietary intervention on in vitro human embryo development: the Preconception Dietary Supplements in Assisted Reproduction double-blinded randomized controlled trial. Fertil Steril. 2020;113(2):260–9. [DOI] [PubMed] [Google Scholar]
  • 21.Vujkovic M, de Vries JH, Lindemans J, Macklon NS, van der Spek PJ, Steegers EAP, Steegers-Theunissen RPM. The preconception Mediterranean dietary pattern in couples undergoing in vitro fertilization/intracytoplasmic sperm injection treatment increases the chance of pregnancy. Fertil Steril. 2010;94(6):2096–101. [DOI] [PubMed] [Google Scholar]
  • 22.Dejong K, Olyaei A, Lo JO. Alcohol use in pregnancy. Clin Obstet Gynecol. 2019;62(1):142–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Christ A, Lauterbach M, Latz E. Western diet and the immune system: an inflammatory connection. Immunity. 2019;51(5):794–811. [DOI] [PubMed] [Google Scholar]
  • 24.Bentov Y. “A Western diet side story”: the effects of transitioning to a Western-type diet on fertility. Endocrinology. 2014;155(7):2341–2. [DOI] [PubMed] [Google Scholar]
  • 25.Ravisankar S, Ting AY, Murphy MJ, Redmayne N, Wang D, McArthur CA, Takahashi DL, Kievit P, Chavez SL, Hennebold JD. Short-term Western-style diet negatively impacts reproductive outcomes in primates. JCI Insight. [Internet] 2021; [cited 2021 Apr 7];6(4). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934943/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Grieger JA, Grzeskowiak LE, Bianco-Miotto T, Jankovic-Karasoulos T, Moran LJ, Wilson RL, Leemaqz SY, Poston L, McCowan L, Kenny LCet al. . Pre-pregnancy fast food and fruit intake is associated with time to pregnancy. Hum Reprod. 2018;33(6):1063–70. [DOI] [PubMed] [Google Scholar]
  • 27.Bishop CV, Takahashi D, Mishler E, Slayden OD, Roberts CT, Hennebold J, True C. Individual and combined effects of 5-year exposure to hyperandrogenemia and Western-style diet on metabolism and reproduction in female rhesus macaques. Hum Reprod. 2021;36(2):444–54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Ros E. The PREDIMED study. Endocrinol Diabetes Nutr. 2017;64(2):63–6. [DOI] [PubMed] [Google Scholar]
  • 29.Ros E, Martínez-González MA, Estruch R, Salas-Salvadó J, Fitó M, Martínez JA, Corella D. Mediterranean diet and cardiovascular health: teachings of the PREDIMED study. Adv Nutr. 2014;5(3):330S–6S. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Guasch-Ferré M, Salas-Salvadó J, Ros E, Estruch R, Corella D, Fitó M, Martínez-González MA; PREDIMED Investigators . The PREDIMED trial, Mediterranean diet and health outcomes: how strong is the evidence?. Nutr Metab Cardiovasc Dis. 2017;27(7):624–32. [DOI] [PubMed] [Google Scholar]
  • 31.Forman D, Bulwer BE. Cardiovascular disease: optimal approaches to risk factor modification of diet and lifestyle. Curr Treat Options Cardiovasc Med. 2006;8(1):47–57. [DOI] [PubMed] [Google Scholar]
  • 32.Korre M, Tsoukas MA, Frantzeskou E, Yang J, Kales SN. Mediterranean diet and workplace health promotion. Curr Cardiovasc Risk Rep. 2014;8(12):416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Willis SK, Wise LA, Wesselink AK, Rothman KJ, Mikkelsen EM, Tucker KL, Trolle E, Hatch EE. Glycemic load, dietary fiber, and added sugar and fecundability in 2 preconception cohorts. Am J Clin Nutr. 2020;112(1):27–38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility. Eur J Clin Nutr. 2009;63(1):78–86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hatch EE, Wesselink AK, Hahn KA, Michiel JJ, Mikkelsen EM, Sorensen HT, Rothman KJ, Wise LA. Intake of sugar-sweetened beverages and fecundability in a North American preconception cohort. Epidemiology. 2018;29(3):369–78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Machtinger R, Gaskins AJ, Mansur A, Adir M, Racowsky C, Baccarelli AA, Hauser R, Chavarro JE. Association between preconception maternal beverage intake and in vitro fertilization outcomes. Fertil Steril. 2017;108(6):1026–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Schliep KC, Schisterman EF, Mumford SL, Pollack AZ, Perkins NJ, Ye A, Zhang CJ, Stanford JB, Porucznik CA, Hammoud AOet al. . Energy-containing beverages: reproductive hormones and ovarian function in the BioCycle Study. Am J Clin Nutr. 2013;97(3):621–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Hohos NM, Skaznik-Wikiel ME. High-fat diet and female fertility. Endocrinology. 2017;158(8):2407–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Dietary fatty acid intakes and the risk of ovulatory infertility. Am J Clin Nutr. 2007;85(1):231–7. [DOI] [PubMed] [Google Scholar]
  • 40.Mumford SL, Chavarro JE, Zhang C, Perkins NJ, Sjaarda LA, Pollack AZ, Schliep KC, Michels KA, Zarek SM, Plowden TCet al. . Dietary fat intake and reproductive hormone concentrations and ovulation in regularly menstruating women. Am J Clin Nutr. 2016;103(3):868–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Willett W. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet North Am Ed. 1993;341(8845):581–5. [DOI] [PubMed] [Google Scholar]
  • 42.L'Abbé MR, Stender S, Skeaff CM, Ghafoorunissa TM. Approaches to removing trans fats from the food supply in industrialized and developing countries. Eur J Clin Nutr. 2009;63(Suppl 2):S50–67.19190645 [Google Scholar]
  • 43.Wise LA, Wesselink AK, Tucker KL, Saklani S, Mikkelsen EM, Cueto H, Riis AH, Trolle E, McKinnon CJ, Hahn KAet al. . Dietary fat intake and fecundability in 2 preconception cohort studies. Am J Epidemiol. 2018;187(1):60–74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Lefevre M, Lovejoy JC, Smith SR, Delany JP, Champagne C, Most MM, Denkins Y, de Jonge L, Rood J, Bray GA. Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism. 2005;54(12):1652–8. [DOI] [PubMed] [Google Scholar]
  • 45.Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr. 2004;79(6):969–73. [DOI] [PubMed] [Google Scholar]
  • 46.Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr. 2004;79(4):606–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Missmer SA, Chavarro JE, Malspeis S, Bertone-Johnson ER, Hornstein MD, Spiegelman D, Barbieri RL, Willett WC, Hankinson SE. A prospective study of dietary fat consumption and endometriosis risk. Hum Reprod. 2010;25(6):1528–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Downs SM, Bloem MZ, Zheng M, Catterall E, Thomas B, Veerman L, Wu JH. The impact of policies to reduce trans fat consumption: a systematic review of the evidence. Curr Dev Nutr. 2017;1:(12):cdn.117.000778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Li K, Huang T, Zheng J, Wu K, Li D. Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor α: a meta-analysis. PLoS One. 2014;9(2):e88103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Wathes DC, Abayasekara DRE, Aitken RJ. Polyunsaturated fatty acids in male and female reproduction. Biol Reprod. 2007;77(2):190–201. [DOI] [PubMed] [Google Scholar]
  • 52.Hammiche F, Vujkovic M, Wijburg W, de Vries JHM, Macklon NS, Laven JSE, Steegers-Theunissen RPM. Increased preconception omega-3 polyunsaturated fatty acid intake improves embryo morphology. Fertil Steril. 2011;95(5):1820–3. [DOI] [PubMed] [Google Scholar]
  • 53.Mumford SL, Browne RW, Kim K, Nichols C, Wilcox B, Silver RM, Connell MT, Holland TL, Kuhr DL, Omosigho URet al. . Preconception plasma phospholipid fatty acids and fecundability. J Clin Endocrinol Metab. 2018;103:4501–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Jungheim ES, Frolova AI, Jiang H, Riley JK. Relationship between serum polyunsaturated fatty acids and pregnancy in women undergoing in vitro fertilization. J Clin Endocrinol Metab. 2013;98(8):E1364–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Chiu Y-H, Karmon AE, Gaskins AJ, Arvizu M, Williams PL, Souter I, Rueda BR, Hauser R, Chavarro JE; EARTH Study Team . Serum omega-3 fatty acids and treatment outcomes among women undergoing assisted reproduction. Hum Reprod. 2018;33(1):156–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Wise LA, Willis SK, Mikkelsen EM, Wesselink AK, Sørensen HT, Rothman KJ, Tucker KL, Trolle E, Vinceti M, Hatch EE. The association between seafood intake and fecundability: analysis from two prospective studies. Nutrients. 2020;12(8):2276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Yang K, Zeng L, Bao T, Ge J. Effectiveness of omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol. 2018;16(1):27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Al-Safi ZA, Liu H, Carlson NE, Chosich J, Harris M, Bradford AP, Robledo C, Eckel RH, Polotsky AJ. Omega-3 fatty acid supplementation lowers serum FSH in normal weight but not obese women. J Clin Endocrinol Metab. 2016;101(1):324–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Nassan FL, Chiu Y-H, Vanegas JC, Gaskins AJ, Williams PL, Ford JB, Attaman J, Hauser R, Chavarro JE. Intake of protein-rich foods in relation to outcomes of infertility treatment with assisted reproductive technologies. Am J Clin Nutr. 2018;108(5):1104–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Stanhiser J, Jukic AMZ, Steiner AZ. Serum omega-3 and omega-6 fatty acid concentrations and natural fertility. Hum Reprod. 2020;35(4):950–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Gaskins AJ, Sundaram R, Buck Louis GM, Chavarro JE. Seafood intake, sexual activity, and time to pregnancy. J Clin Endocrinol Metab. 2018;103(7):2680–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Comerford KB, Ayoob KT, Murray RD, Atkinson SA. The role of avocados in maternal diets during the periconceptional period, pregnancy, and lactation. Nutrients. [Internet]. 2016; [cited 2020 Dec 30];8(5):313. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4882725/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Chavarro JE, Rich-Edwards JW, Rosner B, Willett WC. A prospective study of dairy foods intake and anovulatory infertility. Hum Reprod. 2007;22(5):1340–7. [DOI] [PubMed] [Google Scholar]
  • 64.Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med. 2010;153(12):790–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2013;97(4):854–61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Wise LA, Wesselink AK, Mikkelsen EM, Cueto H, Hahn KA, Rothman KJ, Tucker KL, Sørensen HT, Hatch EE. Dairy intake and fecundability in 2 preconception cohort studies. Am J Clin Nutr. 2017;105(1):100–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Harris HR, Chavarro JE, Malspeis S, Willett WC, Missmer SA. Dairy-food, calcium, magnesium, and vitamin D intake and endometriosis: a prospective cohort study. Am J Epidemiol. 2013;177(5):420–30. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Nodler JL, Harris HR, Chavarro JE, Frazier AL, Missmer SA. Dairy consumption during adolescence and endometriosis risk. Am J Obstet Gynecol. 2020;222(3):257.e1–257.e16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Afeiche MC, Chiu Y-H, Gaskins AJ, Williams PL, Souter I, Wright DL, Hauser R, Chavarro JE; EARTH Study Team . Dairy intake in relation to in vitro fertilization outcomes among women from a fertility clinic. Hum Reprod. 2016;31(3):563–71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Protein intake and ovulatory infertility. Am J Obstet Gynecol. 2008;198(2):210.e1–e7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Mumford SL, Alohali A, Wactawski-Wende J. Dietary protein intake and reproductive hormones and ovulation: the BioCycle study. Fertil Steril. 2015;104(3):e2. [Google Scholar]
  • 72.Walters KA, Handelsman DJ. Role of androgens in the ovary. Mol Cell Endocrinol. 2018;465:36–47. [DOI] [PubMed] [Google Scholar]
  • 73.Souter I, Chiu Y-H, Batsis M, Afeiche MC, Williams PL, Hauser R, Chavarro JE. The association of protein intake (amount and type) with ovarian antral follicle counts among infertile women: results from the EARTH prospective study cohort. BJOG. 2017;124(10):1547–55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Farshchi H, Rane A, Love A, Kennedy RL. Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management. J Obstet Gynaecol. 2007;27(8):762–73. [DOI] [PubMed] [Google Scholar]
  • 75.Gaskins AJ, Chavarro JE. Diet and fertility: a review. Am J Obstet Gynecol. 2018;218(4):379–89. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Lawrence JM, Watkins ML, Chiu V, Erickson JD, Petitti DB. Food fortification with folic acid and rate of multiple births, 1994–2000. Birth Defects Res A Clin Mol Teratol. 2004;70(12):948–52. [DOI] [PubMed] [Google Scholar]
  • 77.Cueto HT, Riis AH, Hatch EE, Wise LA, Rothman KJ, Sørensen HT, Mikkelsen EM. Folic acid supplement use and menstrual cycle characteristics: a cross-sectional study of Danish pregnancy planners. Ann Epidemiol. 2015;25(10):723–729.e1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Murto T, Skoog Svanberg A, Yngve A, Nilsson TK, Altmäe S, Wånggren K, Salumets A, Stavreus-Evers A. Folic acid supplementation and IVF pregnancy outcome in women with unexplained infertility. Reprod Biomed Online. 2014;28(6):766–72. [DOI] [PubMed] [Google Scholar]
  • 79.Gaskins AJ, Mumford SL, Chavarro JE, Zhang C, Pollack AZ, Wactawski-Wende J, Perkins NJ, Schisterman EF. The impact of dietary folate intake on reproductive function in premenopausal women: a prospective cohort study. PLoS One. 2012;7(9):e46276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Marci R, Lisi F, Soave I, Lo Monte G, Patella A, Caserta D, Moscarini M. Impact of 677C>T mutation of the 5,10-methylenetetrahydrofolate reductase on IVF outcome: is screening necessary for all infertile women?. Genet Test Mol Biomarkers. 2012;16:1011–14. [DOI] [PubMed] [Google Scholar]
  • 81.Haggarty P, McCallum H, McBain H, Andrews K, Duthie S, McNeill G, Templeton A, Haites N, Campbell D, Bhattacharya S. Effect of B vitamins and genetics on success of in-vitro fertilisation: prospective cohort study. Lancet North Am Ed. 2006;367(9521):1513–19. [DOI] [PubMed] [Google Scholar]
  • 82.Kim J, Kim H, Roh H, Kwon Y. Causes of hyperhomocysteinemia and its pathological significance. Arch Pharm Res. 2018;41(4):372–83. [DOI] [PubMed] [Google Scholar]
  • 83.Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol. 2000;95:519–24. [DOI] [PubMed] [Google Scholar]
  • 84.Di Simone N, Maggiano N, Caliandro D, Riccardi P, Evangelista A, Carducci B, Caruso A. Homocysteine induces trophoblast cell death with apoptotic features. Biol Reprod. 2003;69(4):1129–34. [DOI] [PubMed] [Google Scholar]
  • 85.Laanpere M, Altmäe S, Stavreus-Evers A, Nilsson TK, Yngve A, Salumets A. Folate-mediated one-carbon metabolism and its effect on female fertility and pregnancy viability. Nutr Rev. 2010;68(2):99–113. [DOI] [PubMed] [Google Scholar]
  • 86.Hajduk M. Wpływ wybranych składników pokarmowych na funkcjonowanie układu rozrodczego u kobiet. Endokrynologia, Otyłość i Zaburzenia Przemiany Materii. 2013;9:29–33. [Google Scholar]
  • 87.Twigt JM, Hammiche F, Sinclair KD, Beckers NG, Visser JA, Lindemans J, de Jong FH, Laven JSE, Steegers-Theunissen RP. Preconception folic acid use modulates estradiol and follicular responses to ovarian stimulation. J Clin Endocrinol Metab. 2011;96(2):E322–29. [DOI] [PubMed] [Google Scholar]
  • 88.Michels KA, Wactawski-Wende J, Mills JL, Schliep KC, Gaskins AJ, Yeung EH, Kim K, Plowden TC, Sjaarda LA, Chaljub ENet al. . Folate, homocysteine and the ovarian cycle among healthy regularly menstruating women. Hum Reprod. 2017;32(8):1743–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Vanaerts LA, Blom HJ, Deabreu RA, Trijbels FJ, Eskes TK, Copius Peereboom-Stegeman JH, Noordhoek J. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos. Teratology. 1994;50(5):348–60. [DOI] [PubMed] [Google Scholar]
  • 90.Chang H, Xie L, Ge H, Wu Q, Wen Y, Zhang D, Zhang Y, Ma H, Gao J, Wang CCet al. . Effects of hyperhomocysteinaemia and metabolic syndrome on reproduction in women with polycystic ovary syndrome: a secondary analysis. Reprod Biomed Online. 2019;38(6):990–8. [DOI] [PubMed] [Google Scholar]
  • 91.Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics. 2015;70(11):765–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Anagnostis P, Karras S, Goulis DG. Vitamin D in human reproduction: a narrative review. Int J Clin Pract. 2013;67(3):225–35. [DOI] [PubMed] [Google Scholar]
  • 93.Halhali A, Acker GM, Garabédian M. 1,25-Dihydroxyvitamin D3 induces in vivo the decidualization of rat endometrial cells. Reproduction. 1991;91(1):59–64. [DOI] [PubMed] [Google Scholar]
  • 94.Lerchbaum E, Obermayer-Pietsch B. Vitamin D and fertility: a systematic review. Eur J Endocrinol. 2012;166(5):765–78. [DOI] [PubMed] [Google Scholar]
  • 95.Kinuta K, Tanaka H, Moriwake T, Aya K, Kato S, Seino Y. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads. Endocrinology. 2000;141(4):1317–24. [DOI] [PubMed] [Google Scholar]
  • 96.Merhi Z, Doswell A, Krebs K, Cipolla M. Vitamin D alters genes involved in follicular development and steroidogenesis in human cumulus granulosa cells. J Clin Endocrinol Metab. 2014;99(6):E1137–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Parikh G, Varadinova M, Suwandhi P, Araki T, Rosenwaks Z, Poretsky L, Seto-Young D. Vitamin D regulates steroidogenesis and insulin-like growth factor binding protein-1 (IGFBP-1) production in human ovarian cells. Horm Metab Res. 2010;42(10):754–7. [DOI] [PubMed] [Google Scholar]
  • 98.Chen Y, Zhi X. Roles of vitamin D in reproductive systems and assisted reproductive technology. Endocrinology. 2020;161(4):bqaa023. [DOI] [PubMed] [Google Scholar]
  • 99.Chiu Y-H, Chavarro JE, Souter I. Diet and female fertility: doctor, what should I eat?. Fertil Steril. 2018;110(4):560–9. [DOI] [PubMed] [Google Scholar]
  • 100.Teegarden D, Donkin SS. Vitamin D: emerging new roles in insulin sensitivity. Nutr Res Rev. 2009;22(1):82–92. [DOI] [PubMed] [Google Scholar]
  • 101.Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67(3):460–4. [DOI] [PubMed] [Google Scholar]
  • 102.He C, Lin Z, Robb SW, Ezeamama AE. Serum vitamin D levels and polycystic ovary syndrome: a systematic review and meta-analysis. Nutrients. 2015;7:4555–77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Muscogiuri G, Altieri B, de Angelis C, Palomba S, Pivonello R, Colao A, Orio F. Shedding new light on female fertility: the role of vitamin D. Rev Endocrin Metab Disord. 2017;18(3):273–83. [DOI] [PubMed] [Google Scholar]
  • 104.van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol. 2005;97(1-2):93–101. [DOI] [PubMed] [Google Scholar]
  • 105.Mariani M, Viganò P, Gentilini D, Camisa B, Caporizzo E, Di Lucia P, Monno A, Candiani M, Somigliana E, Panina-Bordignon P. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. Hum Reprod. 2012;27:2010–19. [DOI] [PubMed] [Google Scholar]
  • 106.Abbas MA, Taha MO, Disi AM, Shomaf M. Regression of endometrial implants treated with vitamin D3 in a rat model of endometriosis. Eur J Pharmacol. 2013;715(1-3):72–5. [DOI] [PubMed] [Google Scholar]
  • 107.Yildirim B, Guler T, Akbulut M, Oztekin O, Sariiz G. 1-alpha,25-Dihydroxyvitamin D3 regresses endometriotic implants in rats by inhibiting neovascularization and altering regulation of matrix metalloproteinase. Postgrad Med. 2014;126(1):104–10. [DOI] [PubMed] [Google Scholar]
  • 108.Miyashita M, Koga K, Izumi G, Sue F, Makabe T, Taguchi A, Nagai M, Urata Y, Takamura M, Harada Met al. . Effects of 1,25-dihydroxy vitamin D3 on endometriosis. J Clin Endocrinol Metab. 2016;101(6):2371–9. [DOI] [PubMed] [Google Scholar]
  • 109.Ciavattini A, Serri M, Delli Carpini G, Morini S, Clemente N. Ovarian endometriosis and vitamin D serum levels. Gynecol Endocrinol. 2017;33(2):164–7. [DOI] [PubMed] [Google Scholar]
  • 110.Cho M-C, Kim JH, Jung MH, Cho IA, Jo HC, Shin JK, Lee SA, Choi WJ, Lee JH. Analysis of vitamin D-binding protein (VDBP) gene polymorphisms in Korean women with and without endometriosis. Clin Exp Reprod Med. 2019;46(3):132–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Buggio L, Somigliana E, Pizzi MN, Dridi D, Roncella E, Vercellini P. 25-Hydroxyvitamin D serum levels and endometriosis: results of a case-control study. Reprod Sci. 2019;26(2):172–7. [DOI] [PubMed] [Google Scholar]
  • 112.Chu J, Gallos I, Tobias A, Tan B, Eapen A, Coomarasamy A. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod. 2018;33(1):65–80. [DOI] [PubMed] [Google Scholar]
  • 113.Abadia L, Gaskins AJ, Chiu Y-H, Williams PL, Keller M, Wright DL, Souter I, Hauser R, Chavarro JE; Environment and Reproductive Health Study Team . Serum 25-hydroxyvitamin D concentrations and treatment outcomes of women undergoing assisted reproduction. Am J Clin Nutr. 2016;104:729–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Arslan S, Akdevelioğlu Y. The relationship between female reproductive functions and vitamin D. J Am Coll Nutr. 2018;37(6):546–51. [DOI] [PubMed] [Google Scholar]
  • 115.Schaefer E, Nock D. The impact of preconceptional multiple-micronutrient supplementation on female fertility. Clin Med Insights Womens Health. [Internet] 2019; [cited 2020 Dec 29];12. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480978/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Schaefer E. Micronutrient deficiency in women living in industrialized countries during the reproductive years: is there a basis for supplementation with multiple micronutrients?. J Nutr Disorders Ther. 2016;6(4):199. [Google Scholar]
  • 117.Hanson MA, Bardsley A, De-Regil LM, Moore SE, Oken E, Poston L, Ma RC, McAuliffe FM, Maleta K, Purandare CNet al. . The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: “Think Nutrition First.” Int J Gynecol Obstet. 2015;131:S213–53. [DOI] [PubMed] [Google Scholar]
  • 118.Marangoni F, Cetin I, Verduci E, Canzone G, Giovannini M, Scollo P, Corsello G, Poli A. Maternal diet and nutrient requirements in pregnancy and breastfeeding. an Italian consensus document. Nutrients. [Internet] 2016; [cited 2020 Dec 29];8(10):629. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084016/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Lu Y, Chen R, Cai J, Huang Z, Yuan H. The management of hypertension in women planning for pregnancy. Br Med Bull. 2018;128(1):75–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Ceko MJ, O'Leary S, Harris HH, Hummitzsch K, Rodgers RJ. Trace elements in ovaries: measurement and physiology. Biol Reprod. 2016;94(4):86. [DOI] [PubMed] [Google Scholar]
  • 121.Hahn KA, Wesselink AK, Wise LA, Mikkelsen EM, Cueto HT, Tucker KL, Vinceti M, Rothman KJ, Sorensen HT, Hatch EE. Iron consumption is not consistently associated with fecundability among North American and Danish pregnancy planners. J Nutr. 2019;149(9):1585–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC. Iron intake and risk of ovulatory infertility. Obstet Gynecol. 2006;108(5):1145–52. [DOI] [PubMed] [Google Scholar]
  • 123.Mills JL, Buck Louis GM, Kannan K, Weck J, Wan Y, Maisog J, Giannakou A, Wu Q, Sundaram R. Delayed conception in women with low-urinary iodine concentrations: a population-based prospective cohort study. Hum Reprod. 2018;33(3):426–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Kuehn B. Iodine deficiency may impair fertility. JAMA. 2018;319:760. [DOI] [PubMed] [Google Scholar]
  • 125.Serafico ME, Ulanday JRC, Alibayan MV, Gironella GMP, Perlas LA. Iodine status in Filipino women of childbearing age. Endocrinol Metab. 2018;33(3):372–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 126.Burns K, Yap C, Mina A, Gunton JE. Iodine deficiency in women of childbearing age: not bread alone?. Asia Pac J Clin Nutr. 2018;27:853–9. [DOI] [PubMed] [Google Scholar]
  • 127.Krela-Kaźmierczak I, Czarnywojtek A, Skoracka K, Rychter AM, Ratajczak AE, Szymczak-Tomczak A, Ruchała M, Dobrowolska A. Is there an ideal diet to protect against iodine deficiency?. Nutrients. 2021;13(2):513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Grieger JA, Grzeskowiak LE, Wilson RL, Bianco-Miotto T, Leemaqz SY, Jankovic-Karasoulos T, Perkins AV, Norman RJ, Dekker GA, Roberts CT. Maternal selenium, copper and zinc concentrations in early pregnancy, and the association with fertility. Nutrients. 2019;11(7):1609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Qazi IH, Angel C, Yang H, Pan B, Zoidis E, Zeng C-J, Han H, Zhou G-B. Selenium, selenoproteins, and female reproduction: a review. Molecules. 2018;23(12):3053. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Hamilton KP, Zelig R, Parker AR, Haggag A. Insulin resistance and serum magnesium concentrations among women with polycystic ovary syndrome. Curr Dev Nutr. 2019;3(11):nzz108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 131.Kanafchian M, Esmaeilzadeh S, Mahjoub S, Rahsepar M, Ghasemi M. Status of serum copper, magnesium, and total antioxidant capacity in patients with polycystic ovary syndrome. Biol Trace Elem Res. 2020;193(1):111–17. [DOI] [PubMed] [Google Scholar]
  • 132.Harding KB, Peña-Rosas JP, Webster AC, Yap CM, Payne BA, Ota E, De-Regil LM. Iodine supplementation for women during the preconception, pregnancy and postpartum period. Cochrane Database Syst Rev. [Internet] 2017; [cited 2020 Dec 31]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6464647/. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 133.Lang AY, Boyle JA, Fitzgerald GL, Teede H, Mazza D, Moran LJ, Harrison C. Optimizing preconception health in women of reproductive age. Minerva Ginecol. 2018;70:99–119. [DOI] [PubMed] [Google Scholar]
  • 134.Shahin AY, Ismail AM, Zahran KM, Makhlouf AM. Adding phytoestrogens to clomiphene induction in unexplained infertility patients–a randomized trial. Reprod Biomed Online. 2008;16(4):580–8. [DOI] [PubMed] [Google Scholar]
  • 135.Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. High dose of phytoestrogens can reverse the antiestrogenic effects of clomiphene citrate on the endometrium in patients undergoing intrauterine insemination: a randomized trial. J Soc Gynecol Investig. 2004;11(5):323–8. [DOI] [PubMed] [Google Scholar]
  • 136.Vanegas JC, Afeiche MC, Gaskins AJ, Mínguez-Alarcón L, Williams PL, Wright DL, Toth TL, Hauser R, Chavarro JE. Soy food intake and treatment outcomes of women undergoing assisted reproductive technology. Fertil Steril. 2015;103(3):749–755.e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 137.Unfer V, Casini ML, Gerli S, Costabile L, Mignosa M, Di Renzo GC. Phytoestrogens may improve the pregnancy rate in in vitro fertilization-embryo transfer cycles: a prospective, controlled, randomized trial. Fertil Steril. 2004;82(6):1509–13. [DOI] [PubMed] [Google Scholar]
  • 138.Jacobsen BK, Jaceldo-Siegl K, Knutsen SF, Fan J, Oda K, Fraser GE. Soy isoflavone intake and the likelihood of ever becoming a mother: the Adventist Health Study-2. Int J Womens Health. 2014;6:377–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 139.Mumford SL, Sundaram R, Schisterman EF, Sweeney AM, Barr DB, Rybak ME, Maisog JM, Parker DL, Pfeiffer CM, Louis GMB. Higher urinary lignan concentrations in women but not men are positively associated with shorter time to pregnancy. J Nutr. 2014;144(3):352–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 140.Wesselink AK, Hatch EE, Mikkelsen EM, Trolle E, Willis SK, McCann SE, Valsta L, Lundqvist A, Tucker KL, Rothman KJet al. . Dietary phytoestrogen intakes of adult women are not strongly related to fecundability in 2 preconception cohort studies. J Nutr. 2020;150(5):1240–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 141.Pabich M, Materska M. Biological effect of soy isoflavones in the prevention of civilization diseases. Nutrients. 2019;11:(7):1660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 142.Eisenbrand G; Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG) . Isoflavones as phytoestrogens in food supplements and dietary foods for special medical purposes. Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG) (shortened version). Mol Nutr Food Res. 2007;51(10):1305–12. [DOI] [PubMed] [Google Scholar]
  • 143.Harper L, Bold J. An exploration into the motivation for gluten avoidance in the absence of coeliac disease. Gastroenterol Hepatol Bed Bench. 2018;11:259–68. [PMC free article] [PubMed] [Google Scholar]
  • 144.Rostami K, Bold J, Parr A, Johnson MW. Gluten-free diet indications, safety, quality, labels, and challenges. Nutrients. 2017;9(8):846. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 145.Castaño M, Gómez-Gordo R, Cuevas D, Núñez C. Systematic review and meta-analysis of prevalence of coeliac disease in women with infertility. Nutrients. 2019;11(8):1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 146.Vici G, Belli L, Biondi M, Polzonetti V. Gluten free diet and nutrient deficiencies: a review. Clin Nutr. 2016;35(6):1236–41. [DOI] [PubMed] [Google Scholar]
  • 147.Gunn B, Murphy KE, Greenblatt EM. Unexplained infertility and undiagnosed celiac disease: study of a multiethnic Canadian population. J Obstet Gynaecol Can. 2018;40(3):293–8. [DOI] [PubMed] [Google Scholar]
  • 148.Lasa JS, Zubiaurre I, Soifer LO. Risk of infertility in patients with celiac disease: a meta-analysis of observational studies. Arq Gastroenterol. 2014;51(2):144–50. [DOI] [PubMed] [Google Scholar]
  • 149.Behrman HR, Kodaman PH, Preston SL, Gao S. Oxidative stress and the ovary. J Soc Gynecol Investig. 2001;8:S40–42. [DOI] [PubMed] [Google Scholar]
  • 150.Ruder EH, Hartman TJ, Blumberg J, Goldman MB. Oxidative stress and antioxidants: exposure and impact on female fertility. Hum Reprod Update. 2008;14(4):345–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 151.Aitken RJ, Clarkson JS. Cellular basis of defective sperm function and its association with the genesis of reactive oxygen species by human spermatozoa. Reproduction. 1987;81(2):459–69. [DOI] [PubMed] [Google Scholar]
  • 152.Wojsiat J, Korczyński J, Borowiecka M, Żbikowska HM. The role of oxidative stress in female infertility and in vitro fertilization. Postepy Hig Med Dosw. 2017;71(0):359–66. [DOI] [PubMed] [Google Scholar]
  • 153.Jackson LW, Schisterman EF, Dey-Rao R, Browne R, Armstrong D. Oxidative stress and endometriosis. Hum Reprod. 2005;20(7):2014–20. [DOI] [PubMed] [Google Scholar]
  • 154.Mohammadi M. Oxidative stress and polycystic ovary syndrome: a brief review. Int J Prev Med. 2019;10(1):86. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 155.Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10(1):49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Smits RM, Mackenzie-Proctor R, Fleischer K, Showell MG. Antioxidants in fertility: impact on male and female reproductive outcomes. Fertil Steril. 2018;110(4):578–80. [DOI] [PubMed] [Google Scholar]
  • 157.Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Antioxidants for female subfertility. Cochrane Database Syst Rev. 2017;7:CD007807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Mier-Cabrera J, Aburto-Soto T, Burrola-Méndez S, Jiménez-Zamudio L, Tolentino MC, Casanueva E, Hernández-Guerrero C. Women with endometriosis improved their peripheral antioxidant markers after the application of a high antioxidant diet. Reprod Biol Endocrinol. 2009;7(1):54. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 159.Mier-Cabrera J, Genera-García M, De la Jara-Díaz J, Perichart-Perera O, Vadillo-Ortega F, Hernández-Guerrero C. Effect of vitamins C and E supplementation on peripheral oxidative stress markers and pregnancy rate in women with endometriosis. Int J Gynecol Obstet. 2008;100(3):252–6. [DOI] [PubMed] [Google Scholar]
  • 160.Hernández Guerrero CA, Bujalil Montenegro L, de la Jara Díaz J, Mier Cabrera J, Bouchán Valencia P. Endometriosis and deficient intake of antioxidants molecules related to peripheral and peritoneal oxidative stress. Ginecol Obstet Mex. 2006;74:20–8. [PubMed] [Google Scholar]
  • 161.Kurdoglu Z, Ozkol H, Tuluce Y, Koyuncu I. Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome. J Endocrinol Invest. 2012;35:317–21. [DOI] [PubMed] [Google Scholar]
  • 162.Mohan SK. Lipid peroxidation, glutathione, ascorbic acid, vitamin E, antioxidant enzyme and serum homocysteine status in patients with polycystic ovary syndrome. Biol Med. 2009;1(3):44–9. [Google Scholar]
  • 163.Laganà AS, Garzon S, Casarin J, Franchi M, Ghezzi F. Inositol in polycystic ovary syndrome: restoring fertility through a pathophysiology-based approach. Trends Endocrinol Metab. 2018;29(11):768–80. [DOI] [PubMed] [Google Scholar]
  • 164.Zheng X, Lin D, Zhang Y, Lin Y, Song J, Li S, Sun Y. Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET. Medicine (Baltimore). 2017;96(49):e8842. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 165.Pundir J, Psaroudakis D, Savnur P, Bhide P, Sabatini L, Teede H, Coomarasamy A, Thangaratinam S. Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomised trials. BJOG. 2018;125(3):299–308. [DOI] [PubMed] [Google Scholar]
  • 166.Dionyssopoulou E, Vassiliadis S, Evangeliou A, Koumantakis EE, Athanassakis I. Constitutive or induced elevated levels of L-carnitine correlate with the cytokine and cellular profile of endometriosis. J Reprod Immunol. 2005;65(2):159–70. [DOI] [PubMed] [Google Scholar]
  • 167.Genazzani AD, Lanzoni C, Ricchieri F, Santagni S, Rattighieri E, Chierchia E, Monteleone P, Jasonni VM. Acetyl-L-carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea. J Endocrinol Invest. 2011;34(4):287–91. [DOI] [PubMed] [Google Scholar]
  • 168.Samimi M, Jamilian M, Ebrahimi FA, Rahimi M, Tajbakhsh B, Asemi Z. Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial. Clin Endocrinol (Oxf). 2016;84(6):851–7. [DOI] [PubMed] [Google Scholar]
  • 169.Agarwal A, Sengupta P, Durairajanayagam D. Role of L-carnitine in female infertility. Reprod Biol Endocrinol. 2018;16(1):5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 170.Pekala J, Patkowska-Sokoła B, Bodkowski R, Jamroz D, Nowakowski P, Lochyński S, Librowski T. L-carnitine—metabolic functions and meaning in humans life. Curr Drug Metab. 2011;12(7):667–78. [DOI] [PubMed] [Google Scholar]
  • 171.El Sharkwy IA, Abd El Aziz WM. Randomized controlled trial of N-acetylcysteine versus l-carnitine among women with clomiphene-citrate-resistant polycystic ovary syndrome. Int J Gynecol Obstet. 2019;147(1):59–64. [DOI] [PubMed] [Google Scholar]
  • 172.Behrouzi Lak T, Hajshafiha M, Nanbakhsh F, Oshnouei S. N-acetyl cysteine in ovulation induction of PCOS women underwent intrauterine insemination: an RCT. Int J Reprod Biomed. 2017;15:203–8. [PMC free article] [PubMed] [Google Scholar]
  • 173.Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(1):35–56. [DOI] [PubMed] [Google Scholar]
  • 174.He F-F, Li Y-M. Role of gut microbiota in the development of insulin resistance and the mechanism underlying polycystic ovary syndrome: a review. J Ovarian Res. 2020;13(1):73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 175.Silva MSB, Giacobini P. Don't trust your gut: when gut microbiota disrupt fertility. Cell Metab. 2019;30(4):616–18. [DOI] [PubMed] [Google Scholar]
  • 176.Lyngsø J, Ramlau-Hansen CH, Bay B, Ingerslev HJ, Hulman A, Kesmodel US. Association between coffee or caffeine consumption and fecundity and fertility: a systematic review and dose-response meta-analysis. Clin Epidemiol. 2017;9:699–719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 177.Greenwood DC, Thatcher NJ, Ye J, Garrard L, Keogh G, King LG, Cade JE. Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2014;29(10):725–34. [DOI] [PubMed] [Google Scholar]
  • 178.James JE. Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be. BMJ Evidence-Based Medicine. [Internet] 2020; [cited 2021 Apr 10]. Available from: https://ebm.bmj.com/content/early/2020/09/01/bmjebm-2020-111432, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 179. EFSA NDA Panel (EFSA Panel on Dietetic Products, Nutrition and Allergies), 2015. Scientific Opinion on the safety of caffeine. EFSA J. 2015;13(5):4102. [Google Scholar]
  • 180. Moderate caffeine consumption during pregnancy. Committee Opinion No. 462. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2010;116:467–8. [DOI] [PubMed] [Google Scholar]
  • 181.Fan D, Liu L, Xia Q, Wang W, Wu S, Tian G, Liu Y, Ni J, Wu S, Guo Xet al. . Female alcohol consumption and fecundability: a systematic review and dose-response meta-analysis. Sci Rep. 2017;7(1):13815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 182.Granato A, Dering B. Alcohol and the developing brain: why neurons die and how survivors change. Int J Mol Sci. 2018;19(10):2992. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Advances in Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES